Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Decibel Therapeutics, Inc. (DBTX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Decibel Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1656536.
Total stock buying since 2021: $75,826,376.
Total stock sales since 2021: $118,069.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 4,218,332 | $75,826,376 | 15,946 | $118,069 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-12 | 0 | $0 | 5,291 | $33,608 | 0 | $0 |
| 2021-11 | 0 | $0 | 5,291 | $43,979 | 0 | $0 |
| 2021-10 | 0 | $0 | 5,364 | $40,482 | 0 | $0 |
| 2021-09 | 10,000 | $76,400 | 0 | $0 | 0 | $0 |
| 2021-02 | 4,208,332 | $75,749,976 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-02 | Trask Anna (See Remarks) | Sale | 5,291 | 6.35 | 33,608 |
| 2021-11-03 | Trask Anna (See Remarks) | Sale | 378 | 8.34 | 3,152 |
| 2021-11-02 | Trask Anna (SEE REMARKS) | Sale | 4,913 | 8.31 | 40,827 |
| 2021-10-14 | Trask Anna (See Remarks) | Sale | 5,364 | 7.55 | 40,482 |
| 2021-09-15 | Reid Laurence (President and Chief Executive) | Buy | 10,000 | 7.64 | 76,400 |
| 2021-02-17 | Foy Matthew (Director) | Buy | 150,000 | 18.00 | 2,700,000 |
| 2021-02-17 | Casdin Partners Master Fund, L.p. (10% Owner) | Buy | 575,000 | 18.00 | 10,350,000 |
| 2021-02-17 | Thompson Peter A. (Director) | Buy | 1,666,666 | 18.00 | 29,999,988 |
| 2021-02-17 | Orbimed Capital Llc (Director) | Buy | 1,666,666 | 18.00 | 29,999,988 |
| 2021-02-17 | Glaxosmithkline Plc | Buy | 150,000 | 18.00 | 2,700,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of DBTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Decibel Therapeutics, Inc. (symbol DBTX, CIK number 1656536) see the Securities and Exchange Commission (SEC) website.